Perioperative Cancer Care in the Context of Limited Resources during the COVID-19 Pandemic: Brazilian Society of Surgical Oncology Recommendations

Abstract

Background. As the COVID-19 pandemic moves from rich to poor nations, the healthcare systems of developing countries have to deal with this extra burden. As cancer care cannot stop and surgery is the main mechanism for cure and palliation, it is important to provide safe and rational access to cancer surgery during the COVID-19 pandemic. Methods. From April 1st to May 1st, the committee of the Brazilian Society of Surgical Oncology (BSSO) was responsible for reviewing the literature and writing recommendations for perioperative cancer care in the context of limited resources during the pandemic. The recommendations were submitted to the BSSO board of directors. The orientations that were not consensual were removed and the suggestions were added to the text. From May 15 to 30th, the committee revised the recommendations, aligned them with the objectives of the work and standardize the text. Discussion. The rational use of resources to reduce the risk of surgical cancer patients being operated on during the incubation period of a corona virus infection is important in this context. Prevalence of corona virus in the region, the need for surgery, surgical complexity, patient age and comorbidities, and availability of corona virus testing are central aspects in this matter and are discussed. Conclusions. We present a protocol, focused on the patients' outcomes, for safe and rational use of resources to reduce the risk of surgical cancer patients being operated on during the virus incubation period, in the context of areas with limited resources.

Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system

“…Others have described operational changes in their management of breast cancer [ 4 – 7 , 11 , 17 ]. One group promoted the use of neoadjuvant systemic therapies to delay definitive surgery until it had personal protective equipment and resources to resume breast cancer surgery [ 18 ].…”

Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence

“…15 Considering that RT-PCR has a false-negative rate of 20%-30%, 51 < 10% of COVID-19–infected patients will inadvertently undergo surgery during the incubation period with this approach. 16 …”

“…To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and other technical documents. 4,9,10,[13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] The data gathered were discussed on an online platform (Within3), covering topics regarding diagnosis, treatment, and management of patients with BC in clinical settings routinely encountered by HCPs amid the COVID-19 pandemic.…”

Oncological Surgery During the COVID-19 Pandemic: Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection

“…These discrepancies may be due to the difference in how the pandemic affected the different study sites and the pandemic pattern during the study periods. 22 , 24 – 28 Brazil and the city of Sao Paulo have been heavily affected by the pandemic, and this study was conducted at a time when the country and city were massively affected—the so-called “first wave.”…”